MFA Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398K Buy
332
+21
+7% +$21.5K 0.07% 76
2026
Q1
$286K Buy
311
+5
+2% +$5.07K 0.06% 76
2025
Q4
$329K Hold
306
0.07% 75
2025
Q3
$233K Buy
306
+15
+5% +$11.2K 0.05% 87
2025
Q2
$227K Sell
291
-75
-20% -$58.3K 0.05% 84
2025
Q1
$302K Hold
366
0.07% 74
2024
Q4
$283K Buy
366
+24
+7% +$19.9K 0.07% 66
2024
Q3
$303K Hold
342
0.07% 77
2024
Q2
$310K Buy
342
+76
+29% +$60.8K 0.07% 78
2024
Q1
$207K Buy
+266
New +$189K 0.05% 84

Other funds holding LLY

MFA Wealth Advisors's LLY Position: Q2 2026 in Review

MFA Wealth Advisors increased its Eli Lilly (LLY) stake by 6.8% in Q2 2026, buying an estimated $21.5K and bringing the position to 332 shares worth $398K. The position accounts for 0.07% of the portfolio, ranked #76.

MFA Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MFA Wealth Advisors held 332 shares of Eli Lilly worth $398K as of Q2 2026.
  • MFA Wealth Advisors bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.07% of MFA Wealth Advisors's portfolio in Q2 2026, its #76 holding.
  • MFA Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MFA Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.